Suppr超能文献

伞式评价内脏手术围手术期免疫营养的疗效。

Umbrella review of the efficacy of perioperative immunonutrition in visceral surgery.

机构信息

Department of Digestive Surgery, University Hospital CHU Clermont-Ferrand, France; Francophone Group for Enhanced Recovery After Surgery (GRACE), France.

Department of Digestive Surgery, University Hospital CHU Clermont-Ferrand, France.

出版信息

Clin Nutr ESPEN. 2022 Apr;48:99-108. doi: 10.1016/j.clnesp.2022.02.015. Epub 2022 Feb 24.

Abstract

INTRODUCTION

Immunonutrition (IN) is used in major visceral surgery to reduce postoperative complications. This umbrella review (review of reviews) collects and analyses data on the efficacy of perioperative IN.

METHODS

The review was conducted in accordance with PRISMA 2020 guidelines. Inclusion criteria were meta-analyses comparing IN with normal diet or isocaloric isonitrogenous feeding. The primary outcome was infectious complications. Secondary outcomes were overall morbidity, hospital length of stay and mortality. Methodological quality was evaluated using AMSTAR-2. Overlap and certainty of evidence (GRADE) were assessed.

RESULTS

Twenty meta-analyses (MAs) were included in the umbrella review: eleven on various abdominal surgeries (one MA was considered twice) and eight on pancreatic, oesophageal, hepatic, or colorectal surgeries. Overall, IN was associated with significantly fewer postoperative infectious complications (OR 0.60 [0.54-0.65], random effect model) but with substantial heterogeneity (I = 64%), and less postoperative morbidity (OR 0.78 [0.74-0.81], I = 30.3%). Excluding three MAs with heterogeneity did not alter the results. The overlap between the MAs was slight, with a corrected covered area of 0.13. There was no significant difference in the timing of IN (preoperative, postoperative or perioperative).

CONCLUSION

This umbrella review confirms the beneficial effect of IN in visceral surgery. Some practical questions remain unanswered: optimal timing of IN, in which surgical speciality it is best used, and its utility in enhanced recovery programmes.

REGISTRATION IN PROSPERO

CRD42021255177.

摘要

简介

免疫营养(IN)用于大型内脏手术中,以减少术后并发症。本综述(综述的综述)收集并分析了围手术期 IN 的疗效数据。

方法

本综述按照 PRISMA 2020 指南进行。纳入标准为比较 IN 与正常饮食或等热量等氮喂养的荟萃分析。主要结局是感染性并发症。次要结局是总发病率、住院时间和死亡率。使用 AMSTAR-2 评估方法学质量。评估了重叠和证据确定性(GRADE)。

结果

本综述纳入了 20 项荟萃分析(MA):11 项关于各种腹部手术(1 项 MA 被考虑了两次)和 8 项关于胰腺、食管、肝脏或结直肠手术的 MA。总体而言,IN 与术后感染性并发症显著减少相关(OR 0.60 [0.54-0.65],随机效应模型),但存在显著异质性(I = 64%),术后发病率也较低(OR 0.78 [0.74-0.81],I = 30.3%)。排除 3 项具有异质性的 MA 并未改变结果。MA 之间的重叠很小,校正后涵盖面积为 0.13。IN 的时机(术前、术后或围手术期)没有显著差异。

结论

本综述证实了 IN 在内脏手术中的有益作用。一些实际问题仍未得到解答:IN 的最佳时机、最适合应用于哪些外科专业以及其在强化康复方案中的效用。

注册 PROSPERO:CRD42021255177。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验